SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-17-000085
Filing Date
2017-02-03
Accepted
2017-02-03 13:25:16
Documents
2
Group Members
ORBIMED CAPITAL GP V LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ss29585_sc13g.htm SC 13G 97930
2 JOINT FILING AGREEMENT ss29585_ex99a.htm EX-99.A 13931
  Complete submission text file 0000947871-17-000085.txt   113381
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G

Mailing Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228
Business Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228 0041-0-22-552-1558
ObsEva SA (Subject) CIK: 0001685316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89794 | Film No.: 17571325
SIC: 2834 Pharmaceutical Preparations